Phase II Opportunity Lead product in Phase II clinical trial under exclusive U.S. Army contract presents a potential entry point for defense health research collaborations, contract manufacturing, and potential long-term procurement agreements.

Tinnitus Pipeline Pre-clinical activity for three tinnitus drug candidates indicates opportunities to pitch cardiovascular and nervous system partnering, grant-aligned funding discussions, and potential licensing deals for adjunct therapies.

NIH FundedValidate Historically NIH-funded product development with seven SBIR/STTR grants demonstrates credibility with government grant programs and positions the company for targeted grant renewals and public-sector partnerships.

Small Team Scalability With a lean team, there is a clear path for scalable partnerships in CRO services, clinical operations support, and joint development agreements to accelerate milestones without heavy internal headcount growth.

Evidence Portfolio Multiple patents, published papers, and proven safety records across drug candidates provide a solid foundation for buyer confidence in early-access programs, licensing negotiations, and co-development opportunities.